NCT00659841View on ClinicalTrials.gov

To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401)

PHASE3CompletedINTERVENTIONAL
Enrollment

302

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

December 31, 2004

Study Completion Date

February 28, 2005

Conditions
Rhinitis, Allergic, SeasonalHay Fever
Interventions
DRUG

Ciclesonide

200µg Ciclesonide versus placebo

DRUG

Placebo

placebo

Trial Locations (6)

78028

Altana/Nycomed, Kerrville

78130

Altana/Nycomed, New Braunfels

78205

Altana/Nycomed, San Antonio

78229

Altana/Nycomed, San Antonio

78731

Altana/Nycomed, Austin

78759

Altana/Nycomed, Austin

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY